Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2023 | The importance of addressing patients’ fear of progression and relapse

Lorna Warwick • 24 Apr 2023
EBMT 2023
General

Lorna Warwick, BA, Lymphoma Coalition, Toronto, Canada, emphasizes the importance of addressing cancer patients’ fear of disease progression and relapse, and explains that patients should be encouraged to communicate their fears to their medical team to receive adequate support. This interview took place at the 49th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) held in Paris, France.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Lorna Warwick

2:23
The evidence needs in CAR-T from the patient perspective: capturing the patient experience
Lorna Warwick • 17 Feb 2024
2:20
Comparing patient-reported vs clinical trial side effect incidence for patients receiving CAR-T
Lorna Warwick • 17 Feb 2024
3:20
Improving patient knowledge of medicine relating to CLL
Lorna Warwick • 10 Oct 2023
2:16
The Lymphoma Coalition Global Patient survey: key gaps in health literacy
Lorna Warwick • 10 Oct 2023

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
2:25
The EBMT Trainee Committee: in-person trainee day at EBMT 2024 and upcoming initiatives
Claire Horgan • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals